{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Chronic liver disease",
      "Non-alcoholic fatty liver disease",
      "Obesity",
      "Pediatrics"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34736591",
  "DateCompleted": {
    "Year": "2021",
    "Month": "12",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.pcl.2021.07.013",
      "S0031-3955(21)00132-2"
    ],
    "Journal": {
      "ISSN": "1557-8240",
      "JournalIssue": {
        "Volume": "68",
        "Issue": "6",
        "PubDate": {
          "Year": "2021",
          "Month": "Dec"
        }
      },
      "Title": "Pediatric clinics of North America",
      "ISOAbbreviation": "Pediatr Clin North Am"
    },
    "ArticleTitle": "Pediatric Nonalcoholic Fatty Liver Disease.",
    "Pagination": {
      "StartPage": "1309",
      "EndPage": "1320",
      "MedlinePgn": "1309-1320"
    },
    "Abstract": {
      "AbstractText": [
        "Obesity has led fatty liver disease to become the most common chronic liver disease in children worldwide. Pediatric professional organizations have agreed that screening for fatty liver disease in children is the need of the hour. Once identified, prevention is key through appropriate dietary and activity prescriptions. Research continues to identify key pathways and genetic risk factors that predispose certain children to the more severe manifestations of this silent epidemic. We hope these novel observations lead to breakthrough treatments for these children that are severely impacted, such that they may no longer need liver transplantation as young adults."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Children's Hospital Los Angeles, 4650 Sunset Boulevard, MS #78, Los Angeles, CA 90027, USA."
          }
        ],
        "LastName": "Mitsinikos",
        "ForeName": "Tania",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Children's Hospital Los Angeles, 4650 Sunset Boulevard, MS #78, Los Angeles, CA 90027, USA."
          }
        ],
        "LastName": "Mrowczynski-Hernandez",
        "ForeName": "Paula",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Children's Hospital Los Angeles, 4650 Sunset Boulevard, MS #78, Los Angeles, CA 90027, USA. Electronic address: rkohli@usc.edu."
          }
        ],
        "LastName": "Kohli",
        "ForeName": "Rohit",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Pediatr Clin North Am",
    "NlmUniqueID": "0401126",
    "ISSNLinking": "0031-3955"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "1406-18-4",
      "NameOfSubstance": "Vitamin E"
    },
    {
      "RegistryNumber": "EC 2.6.1.2",
      "NameOfSubstance": "Alanine Transaminase"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Alanine Transaminase"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Diet Therapy"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Elasticity Imaging Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "diagnostic imaging",
        "pathology"
      ],
      "DescriptorName": "Liver"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Liver Transplantation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "prevention & control",
        "therapy"
      ],
      "DescriptorName": "Non-alcoholic Fatty Liver Disease"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Obesity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Ultrasonography"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Vitamin E"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "Disclosure Dr R. Kohli declares Data Safety Monitoring Board/research agreements with Albireo Pharma, Takeda Pharmaceutical Company, Mirum Pharmaceuticals, Vision Pharma, and Epigen Pharma. Dr R. Kohli is a consultant for/received speaking compensation from Intercept Pharmaceuticals, Alexion Pharmaceuticals, and Sanofi-Genzyme. Other authors have nothing to disclose."
}